1Freudenberger RS,Schwarz RP Jr,Brown J,et al.Rationale,design and organisation of an efficacy and safety study of oxypurinol added to standard therapy in patients with NYHA class III-IV congestive heart failure[J].Expert Opin Investig Drugs,2004,13(11):1509-1516.
2De Vecchis R,Cantatrione C,Mazzei D,et al.Non-Ergot Dopamine Agonists Do Not Increase the Risk of Heart Failure in Parkinson’s Disease Patients:A Meta-Analysis of Randomized Controlled Trials[J].J Clin Med Res,2016,8(6):449-460.
3Psotka MA,Teerlink JR.Ivabradine:Role in the Chronic Heart Failure Armamentarium[J].Circulation,2016,133(21):2066-2075.